96978 ⎘
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans; Cytokines; Lymphokines; Interferons; Interferons [IFN] IFN-alpha
Agents and methods for the expression and secretion of peptides and proteins
#302Recombinant fusion interferon for animals
#303Vectors conditionally expressing protein
#304Fusions of antibodies to CD38 and attenuated interferon alpha
#305SEPARATION OF ACETYLATED PROTEINS FROM UNACETYLATED PROTEINS
#306Derivatives of recombinant proteins, homo-multimers of granulocyte colony-stimulating factor and method of preparation thereof
#307DERIVATIVES OF GROWTH HORMONE AND RELATED PROTEINS
#308Targeted interferons demonstrating potent apoptotic and anti-tumor activities
#309Biological active proteins having increased in vivo and/or in vitro stability
#310Expression system with SAR element from IFNα2
#311Recombinant fusion interferon for animals
#312Growth hormone and interferon-alpha 2 glycoproteins produced in plants
#313Treatment with factor ix-albumin fusion protein
#314Treatment with factor VII-albumin fusion protein
#315Multimeric complexes with improved in vivo stability, pharmacokinetics and efficacy
#316Protein complex using an immunoglobulin fragment and method for the preparation thereof
#317Liquid formulations of long-acting interferon alpha conjugates
#318Interferon alpha mutant and its polyethylene glycol derivative
#319USES OF SPATIAL CONFIGURATION TO MODULATE PROTEIN FUNCTION
#320Albumin Fusion Proteins
#321Hyaluronic acid-protein conjugates and method for preparing same
#322Anticancer fusion protein comprising TRAIL and interferon
#323ANTI-SERUM ALBUMIN BINDING VARIANTS
#324Engineered antibody-interferon mutant fusion molecules
#325Methods for making proteins containing free cysteine residues
#326Recombinant human interferon-like proteins and method of treatment using them
#327DESIGN AND USE OF NEW RECOMBINANT INTERFERONS WITH ALTERED SPATIAL CONFIGURATION AND THREE-DIMENSIONAL STRUCTURE
#328Immunoglobulin chimeric monomer-dimer hybrids
#329Chloroplasts engineered to express pharmaceutical proteins
#330COMPOSITIONS AND METHODS FOR IMPROVING PRODUCTION OF RECOMBINANT POLYPEPTIDES
#331ALBUMIN FUSION PROTEINS
#332Peptides for active anti-cytokine immunization
#333DESIGN AND USE OF NEW RECOMBINANT INTERFERONS WITH ALTERED SPATIAL CONFIGURATION AND THREE-DIMENSIONAL STRUCTURE
#334Method for producing interferon alpha 5
#335Crystal of recombinant interferon with altered spatial configuration, three-dimensional structure and uses thereof
#336Selection and characterization of novel plant-derived recombinant human interferons with broad spectrum activity
#337N-TERMINALLY CHEMICALLY MODIFIED PROTEIN COMPOSITIONS AND METHODS
#338EXPRESSION OF BIOLOGICALLY ACTIVE POLYPEPTIDES IN DUCKWEED
#339ALBUMIN FUSION PROTEINS
#340BIOLOGICALLY ACTIVE PROTEINS HAVING INCREASED IN VIVO AND/OR IN VITRO STABILITY
#341UNSTRUCTURED RECOMBINANT POLYMERS AND USES THEREOF
#342Methods of treating lupus
#343Cytokine protein family
#344Albumin fusion proteins
#345Albumin Fusion Proteins
#346Interferon-α (IFN-α) fused proteins comprising IFN-α and a cytoplasmic transduction peptide (CTP)
#347GLYCOSYLATED HUMAN ALPHA INTERFERON MUTEINS, METHOD FOR OBTAINING THEM AND USE
#348Gene vector
#349METHOD OF LABELLING INTERFERONS WITH PEG
#350Peptides for active anti-cytokine immunization
#351Nucleic acid construct having an ovalbumin promotor
#352Methods for making proteins containing free cysteine residues
#353Method of Producing Hydroxyalkyl Starch Derivatives
#354Albumin fusion proteins
#355METHODS AND COMPOSITIONS FOR POLYPEPTIDE ENGINEERING
#356Anti-serum albumin binding variants
#357Anti-serum albumin binding variants
#358CONJUGATES FOR THE ADMINISTRATION OF BIOLOGICALLY ACTIVE COMPOUNDS
#359Inhibitor of Endogenous Human Interferon-gamma
#360Albumin Fusion Proteins
#361Chimeric activators: quantitatively designed protein therapeutics and uses thereof
#362Therapeutic use of interferon-polymer conjugates
#363PURIFICATION OF RECOMBINANTLY PRODUCED INTERFERON
#364C-terminally truncated interferon alpha variants
#365Cysteine variants of interferon gamma
#366Method for the mass production of immunoglobulin constant region
#367Glycoproteins Produced in Plants and Methods of Their Use
#368Inhibitor of Endogenous Human Interferon-Gamma
#369Nucleic acid for plant expression of a fusion protein comprising hydroxyproline O-glycosylation glycomodule
#370Treatment or Prevention of Hepatitis C with Immunomodulator Compounds
#371Cytokine Protein Family
#372Method for preparing recombinant granulocyte colony stimulating factor cysteine muteins
#373Immunogenic compounds comprising peptides of IL1β
#374Immunoglobulin chimeric monomer-dimer hybrids
#375O-LINKED GLYCOSYLATION USING N-ACETYLGLUCOSAMINYL TRANSFERASES
#376Genetically modified human umbilical cord perivascular cells for prophylaxis against or treatment of biological or chemical agents
#377Unstructured recombinant polymers and compositions comprising same
#378Peptides for active anti-cytokine immunization
#379METHOD FOR TARGETED AND SUSTAINED ANTIVIRAL THERAPY
#380Methods for Chemically Synthesizing Immunoglobulin Chimeric Proteins
#381Interferon alpha-2B modified by polyethylene glycol and methods of preparation thereof
#382Crystalline recombinant interferon with altered spatial configuration, three-dimensional structure and uses thereof
#383Efficient production of peptides
#384Interferon-antibody fusion proteins demonstrating potent apoptotic and anti-tumor activities
#385USES OF SPATIAL CONFIGURATION TO MODULATE PROTEIN FUNCTION
#386T CELL RECEPTOR FUSIONS AND CONJUGATES AND METHODS OF USE THERE OF
#387Hydroxyalkyl starch derivatives
#388METHODS AND COMPOSITIONS FOR POLYPEPTIDE ENGINEERING
#389Cytokine protein family
#390PURIFICATION OF NOT-GLYCOSYLATED POLYPEPTIDES
#391PROTEIN STABILIZATION
#392Albumin fusion proteins
#393HYPERGLYCOSYLATED POLYPEPTIDE VARIANTS AND METHODS OF USE
#394INTERFERON FUSION PROTEINS
#395Methods of protein production using ovomucoid regulatory regions
#396Method of Producing Hydroxyalkyl Starch Derivatives
#397Antibodies produced in the avian oviduct
#398N-terminally chemically modified protein compositions and methods
#399Recombinant human interferon-like proteins
#400Interferon-antibody fusion proteins demonstrating potent apoptotic and anti-tumor activities
#401Biological active proteins having increased in vivo and/or in vitro stability
#402Feline granulocyte macrophage colony stimulating factor proteins
#403IMMUNOGLOBULIN FUSION PROTEINS
#404Methods and compositions for treatment of interferon-resistant tumors
#405Production of Recombinant Interferon Proteins
#406COMPOSITIONS AND METHODS FOR IMPROVING PRODUCTION OF RECOMBINANT POLYPEPTIDES
#407Protein Complex Using An Immunoglobulin Fragment and Method For The Preparation Thereof
#408Expression of human interferon in transgenic chloroplasts
#409Interferon alpha-2a modified by polyethylene glycol and methods of preparation thereof
#410Method of using interferon-like potein ZCYTO20 (IL-28A) or ZCYTO22(IL-28B) to treat hepatitis B
#411INTERFERONS, USES AND COMPOSITIONS RELATED THERETO
#412Protease activatable interferon alpha proprotein
#413Albumin Fusion Proteins
#414Biologically active proteins having increased In Vivo and/or In Vitro stability
#415Interferon-antibody fusion proteins demonstrating potent apoptotic and anti-tumor activities
#416Inhibitor of endogenous human interferon-gamma
#417Peptides for active anti-cytokine immunization
#418Human Interferon Molecules and Their Uses
#419Recombinant human interferon-like proteins
#420Recombinant human interferon-like proteins
#421ATTENUATED ONCOLYTIC PARAMYXOVIRUSES ENCODING AVIAN CYTOKINES
#422Interferon alpha mutant and its polyethylene glycol derivative
#423Methods for making proteins containing free cysteine residues
#424GLYCOPROTEINS PRODUCED IN PLANTS AND METHODS OF THEIR USE
#425METHODS OF PRODUCING PEPTIDES IN PLANTS AND PEPTIDES PRODUCED THEREBY
#426Mutant interferon α protein and use thereof
#427Methods for producing a protein using an avian lysozyme promoter
#428METHODS OF PURIFYING PROTEINS FROM EGG WHITE
#429Albumin Fusion Proteins
#430EXPRESSION OF BIOLOGICALLY ACTIVE POLYPEPTIDES IN DUCKWEED
#431Methods for refolding proteins containing free cysteine residues
#432N-terminal modified interferon-alpha
#433Inhibitor of endogenous human interferon-gamma
#434Compositions and methods for delivering nucleotide sequences to vertebrates
#435Antibodies to ZCYTO20 (IL-28A) and ZCYTO22 (IL-28B)
#436Methods and compositions for polypeptide engineering
#437CANINE AND FELINE IMMUNOREGULATORY PROTEINS, NUCLEIC ACID MOLECULES, AND USES THEREOF
#438Albumin Fusion Proteins
#439Albumin Fusion Proteins
#440Albumin Fusion Proteins
#441Compositions comprising modified biologically active polypeptides
#442Interferons of rhesus and cynomolgus origin and uses thereof
#443Albumin Fusion Proteins
#444DERIVATIVES OF GROWTH HORMONE AND RELATED PROTEINS
#445Interferon-alpha polypeptides and conjugates
#446C-terminally truncated interferon
#447Interferon-alpha polypeptides and conjugates
#448Interferon-alpha polypeptides and conjugates
#449Interferon-alpha polypeptides and conjugates
#450Interferon-alpha polypeptides and conjugates
#451POLYNUCLEOTIDES AND POLYPEPTIDES OF THE IFNalpha17 GENE
#452Methods and uses of antibodies in the purification of interferon
#453Cysteine variants of interferon gamma
#454Recombinant human interferon-like proteins
#455Isolated TNF-alpha peptide and pharmaceutical composition thereof
#456Polynucleotides and Polypeptides of the IFNalpha-21 Gene
#457Nucleic acid molecules encoding recombinant interferon-α2 (IFNα2) mutants
#458Chloroplasts Engineering to Express Pharmaceutical Proteins
#459Albumin Fusion Proteins
#460Albumin Fusion Proteins
#461Albumin Fusion Proteins
#462Albumin fusion proteins
#463Albumin Fusion Proteins
#464Albumin Fusion Proteins
#465Peptides for active anti-cytokine immunization
#466Methods for chemically synthesizing immunoglobulin chimeric proteins
#467Interferon-Alpha Polypeptides and Conjugates
#468Evolved interferon-alpha polypeptides
#469Cysteine variants of interferon-gamma
#470Albumin fusion proteins
#471Interferon-alpha polypeptides and conjugates
#472Albumin Fusion Proteins
#473Albumin fusion proteins comprising insulin polypeptides
#474Recombinant interferon α2 (IFNα2) mutants and methods of use thereof
#475Albumin Fusion Proteins
#476G-CSF-albumin fusion proteins
#477Albumin fusion proteins
#478Pegylated human interferon polypeptides
#479Cytokine protein family
#480Process of Producing a Plastid-Targeted Protein in Plant Cells
#481Albumin fusion proteins
#482INSULINOTROPIC PEPTIDE CONJUGATE USING CARRIER SUBSTANCE
#483Human Interferon Molecules and Their Uses
#484Human Interferon Molecules and Their Uses
#485NATRIURETIC PEPTIDE CONJUGATE USING CARRIER SUBSTANCE
#486Method of using interferon-like protein ZCYTO20 (IL-28A) or ZCYTO22 (IL-28B) to treat hepatitis C
#487Interferon-alpha polypeptides and conjugates
#488PROCESS FOR THE FERMENTATIVE PRODUCTION OF PROTEINS
#489Methods of purifying proteins from egg white
#490Transgene expression in a avians
#491Unstructured recombinant polymers and uses thereof
#492Cytokine protein family
#493Interferon-alpha polypeptides and conjugates
#494Albumin fusion proteins
#495Interferon-alpha polypeptides and conjugates
#496Cytokine protein family
#497Albumin fusion proteins
#498CYTOKINE PROTEIN FAMILY
#499Albumin fusion proteins
#500Methods for treating cancer using interferon-ω-expressing polynucleotides
#501INTERFERON-ALPHA POLYPEPTIDES AND CONJUGATES
#502INTERFERON-ALPHA POLYPEPTIDES AND CONJUGATES
#503Drug-Polymer Conjugates
#504Immunoglobulin chimeric monomer-dimer hybrids
#505Biodegradable multi-block polymeric composition capable of sol-gel transition and pharmaceutical composition comprising the same
#506Fusion proteins of interferon alpha muteins with improved properties
#507CYTOKINE PROTEIN FAMILY
#508Canine IL-5 proteins and fragments thereof
#509Cytokine protein family
#510Cytokine protein family
#511C-terminally truncated interferon alpha variants
#512CYTOKINE PROTEIN FAMILY
#513Avians containing a lysozyme promoter transgene
#514Rapid production of high titer virus
#515Interferon-Alpha Polypeptides and Conjugates
#516IgG Fc fragment for a drug carrier and method for the preparation thereof
#517Methods and compositions for polypeptide engineering
#518Erythropoietin: remodeling and glycoconjugation of erythropoietin
#519Interferon-alpha polypeptides and conjugates
#520INTERFERON-ALPHA POLYPEPTIDES AND CONJUGATES
#521Interferon-alpha polypeptides and conjugates
#522Feline granulocyte macrophage colony stimulating factor nucleic acid molecules
#523Low-toxicity, long-circulating human interferon-alpha PEGylated mutants
#524Remodeling and glycoconjugation of peptides
#525Method for the mass production of immunoglobulin constant region
#526Peg-physiologically active polypeptide homodimer complex having prolonged in vivo half-life and process for the preparation thereof
#527Albumin fusion proteins
#528Pharmaceutical composition comprising an immunoglobulin Fc region as a carrier
#529Protein complex using an immunoglobulin fragment and method for the preparation thereof
#530Interferon-IgG fusion
#531Materials and methods for inhibition of IgE production
#532Peptides for active anti-cytokine immunization
#533N-terminally chemically modified protein compositions and methods
#534Expression vectors, transformed host cells and fermentation process for the production of recombinant polypeptides
#535Method for producing recombinant human interferon alpha 2b polypeptide in pichia pastoris
#536Methods and compositions for polypeptide engineering
#537Feline interferon-alpha proteins
#538Hyperglycosylated polypeptide variants and methods of use
#539Expression of biologically active polypeptides in duckweed
#540Albumin fusion proteins
#541Process for the purification of recombinant polypeptides
#542Methods and compositions for polypeptide engineering
#543Glycoproteins produced in plants and methods of their use
#544Expression of human interferon in transgenic chloroplasts
#545Pharmaceutical proteins, human therapeutics, human serum albumin insulin, native cholera toxic B submitted on transgenic plastids
#546Use of caspase enzymes for maturation of engineered recombinant polypeptide fusions
#547Methods and compositions for polypeptide engineering
#548Cytokine protein family
#549Modified interferon alpha with reduced immunogenicity
#550Pegylated interferon alpha-1b
#551Methods of producing peptides/proteins in plants and peptides/proteins produced thereby
#552C-terminally truncated interferon
#553Hasylated polypeptides
#554Methods and compositions for treatment of interferon-resistant tumors
#555Treatment of ocular lesions
#556Albumin fusion proteins
#557Albumin fusion proteins
#558Interferon-alpha polypeptides and conjugates
#559Immunoglobulin chimeric monomer-dimer hybrids
#560Albumin fusion proteins
#561Method of producing hydroxyalkyl starch derivatives
#562Hydroxyalkyl starch derivatives
#563Cysteine substitution variants of beta interferon
#564COOH-terminally added cysteine variant of the beta interferon
#565Monopegylated growth hormone proteins
#566Albumin fusion proteins comprising GLP-1 polypeptides
#567Cysteine variants of erythropoietin
#568Pharmaceutical compositions of glycoconjugates
#569Albumin fusion proteins
#570Cysteine variants of erythropoietin
#571Uses of spatial configuration to modulate protein function
#572Expression of biologically active polypeptides in duckweed
#573Methods and compositions for polypeptide engineering
#574Cysteine variants of alpha interferon-2
#575Interferon variants with improved properties
#576Transgenic avians with an ovomucoid gene expression control region linked to a nucleotide sequence encoding a heterologous polypeptide
#577Expression and export of interferon-alpha proteins as Fc fusion proteins
#578Immunoglobulin chimeric monomer-dimer hybrids
#579Methods for chemically synthesizing immunoglobulin chimeric proteins
#580Methods for making proteins containing free cysteine residues
#581Glycosylated human interferon alpha isoform
#582Hybrid with interferon-alpha and an immunoglobulin Fc for treatment of tumors and viral infections